Related Experiment Video
Updated: Jun 4, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Probable Antiphospholipid Syndrome Causing Biventricular Thrombi and Cardiogenic Shock
Parth Contractor1, Joseph Deng1, Liam Parker O'Neill2
1Department of Internal Medicine, University of Maryland Medical Center, Baltimore, Maryland, USA.
Extensive intracardiac thrombi, a rare antiphospholipid syndrome (APS) complication, can cause cardiogenic shock. Management is challenging due to limited evidence beyond anticoagulation, especially with biventricular involvement.
Area of Science:
- Cardiology
- Hematology
- Immunology
Background:
- Intracardiac thrombi are a rare manifestation of antiphospholipid syndrome (APS).
- Biventricular involvement of intracardiac thrombi in APS is exceedingly uncommon.
- Takotsubo cardiomyopathy can present with cardiogenic shock and intracardiac thrombi.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Venous Thrombosis I: Introduction
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

